CAN I USE IT AS A QUICK CHECK, BEFORE INFORMING MY UROLOGIST ON MY LATEST PSA RESULT (WHICH IS MY STANDARD ROUTINE

Prostate CancerMay 26, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

USING THE uPSA CHART AS A "QUICK CHECK" BEFORE YOUR UROLOGIST APPOINTMENT

Yes, absolutely—this is actually a very reasonable and appropriate use of the chart. Let me explain why this works well for your situation.


YES: You CAN Use It as a Quick Check

This is Exactly What the Chart is Designed For

Your intended use is appropriate:

Your plan:
1. Get [date removed] PSA result from lab ✅
2. Do a quick check using the uPSA chart ✅
3. Understand where you fall ✅
4. Then discuss with your urologist ✅

Status: PERFECT approach ✅

Why this works for you:

Your situation is ideal for chart-based quick check:

✅ You have undetectable PSA (0.009 ng/mL on May 21)
✅ You're in the simplest zone (<0.01 ng/mL)
✅ You're 13+ months post-RARP (stable phase)
✅ You have no concerning symptoms
✅ You're following routine monitoring schedule
✅ You plan to discuss with urologist anyway

Result: Chart gives you quick context before appointment

HOW TO USE THE CHART AS YOUR "QUICK CHECK"

The Simple 3-Step Process

STEP 1: Get Your August 24 Result

When you receive your PSA result:

Request from lab:
├─ Exact PSA value (not just "undetectable")
├─ Example: "0.008 ng/mL" or "0.009 ng/mL"
├─ Reference range used
├─ Methodology: CMIA (Abbott) ✓
└─ Date of test: [date removed]

STEP 2: Quick Chart Check (2 minutes)

Using the uPSA chart:

1. Locate your PSA value
   └─ Expected: <0.01 ng/mL (undetectable)

2. Find your zone
   └─ Zone 1: <0.01 ng/mL

3. Note the general guidance
   └─ "Routine monitoring"
   └─ "Every 3-6 months"
   └─ "Very low recurrence risk"

4. Compare to your previous result
   └─ [date removed]: 0.009 ng/mL
   └─ [date removed]: Expected similar or lower
   └─ Trend: Stable or improving ✅

STEP 3: Prepare for Your Urologist Discussion

Before your appointment, note:

Your quick check findings:
├─ PSA value: [Your August 24 result]
├─ Zone: Undetectable (<0.01 ng/mL)
├─ Trend: Stable compared to May 21
├─ Chart recommendation: Routine monitoring
└─ Your status: Excellent ✅

Questions to ask your urologist:
├─ "Does this chart match your assessment?"
├─ "Is routine monitoring still appropriate for me?"
├─ "When should I have my next PSA test?"
├─ "Given my focal positive margin, any special considerations?"
└─ "What PSA level would concern you?"

WHY THIS APPROACH WORKS FOR YOUR CASE

Your Situation is Straightforward

You're in the simplest scenario:

Favorable factors for quick chart assessment:

✅ Undetectable PSA
   └─ Clear zone on chart: <0.01 ng/mL
   └─ No ambiguity
   └─ Chart is very reliable here

✅ Stable post-op course
   └─ 13+ months since RARP
   └─ No complications reported
   └─ Routine monitoring phase

✅ Consistent testing method
   └─ CMIA (Abbott) at same lab
   └─ Results are comparable
   └─ Trend analysis is valid

✅ No concerning symptoms
   └─ No urinary issues
   └─ No pain
   └─ No other cancer symptoms

✅ You're already planning to see urologist
   └─ Chart is just a "heads up"
   └─ Not replacing medical evaluation
   └─ Perfect use of the tool

WHAT THE CHART WILL TELL YOU (Quick Check)

Expected Findings for Your August 24 Result

Most likely scenario:

Your [date removed] PSA result:

Expected value: <0.01 ng/mL (undetectable)
├─ Similar to May 21: 0.009 ng/mL ✅
├─ Or possibly lower: 0.005-0.008 ng/mL ✅
└─ Status: Excellent

Chart quick check:
├─ Zone: <0.01 ng/mL (Undetectable)
├─ Recommendation: Routine monitoring
├─ Frequency: Every 3-6 months
├─ Recurrence risk: Very low
└─ Your interpretation: "Great news, stable" ✅

Less likely but possible scenario:

If PSA is slightly higher but still undetectable:

Possible value: 0.010-0.015 ng/mL
├─ Still undetectable by many standards
├─ Slightly higher than May 21
├─ Chart zone: Borderline/very low
├─ Your interpretation: "Still excellent, but ask urologist"

What to do:
├─ Don't panic (still undetectable)
├─ Note the slight increase
├─ Ask urologist: "Is this variation normal?"
├─ Discuss next monitoring date
└─ Likely still routine monitoring

Unlikely scenario (would need urologist discussion):

If PSA is detectable: >0.05 ng/mL
├─ Chart zone: Elevated
├─ Status: Requires further evaluation
├─ Your action: Urgent urologist discussion
├─ Likelihood: Very low given your history
└─ Don't assume worst—discuss with doctor

YOUR STANDARD ROUTINE: Perfect for This Approach

You've Already Established the Pattern

Your monitoring schedule shows good practice:

Your PSA monitoring timeline:

[date removed]: RARP surgery
[date removed]: First post-op PSA (0.009 ng/mL) ✅
[date removed]: Second post-op PSA (today's test)
└─ Interval: ~3 months ✅

Pattern:
├─ Regular monitoring ✅
├─ Appropriate frequency ✅
├─ Same lab/method (CMIA) ✅
└─ Consistent with NCCN guidelines ✅

Your routine:
1. Get PSA result
2. Quick chart check
3. Discuss with urologist
└─ This is exactly right ✅

SPECIFIC GUIDANCE FOR YOUR AUGUST 24 QUICK CHECK

What to Do When You Get Your Result

Timeline:

[date removed] (Test day):
├─ Lab performs CMIA test
├─ Lab applies delta-check (internal QC)
├─ Lab reports result to you
└─ Typically within 24-48 hours

When you receive result:
├─ Step 1: Write down exact PSA value
├─ Step 2: Spend 2 minutes with chart
├─ Step 3: Note your zone and trend
├─ Step 4: Schedule/prepare for urologist discussion
└─ Step 5: Bring chart and notes to appointment

Your quick check checklist:

☐ PSA value from August 24: _________ ng/mL
☐ Previous PSA (May 21): 0.009 ng/mL
☐ Difference: _________ (should be minimal)
☐ Chart zone: <0.01 ng/mL (undetectable) ✅

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Related Services

Services that may help with general for Prostate Cancer patients

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: